Drug Shortage Report for JAMP SPIRONOLACTONE
Report ID | 177828 |
Drug Identification Number | 02518848 |
Brand name | JAMP SPIRONOLACTONE |
Common or Proper name | Spironolactone Tablets USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SPIRONOLACTONE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C03DA |
ATC description | POTASSIUM-SPARING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-12-09 |
Estimated end date | 2023-05-31 |
Actual end date | 2023-05-01 |
Shortage status | Resolved |
Updated date | 2023-05-03 |
Company comments | Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-09 | English | Compare |
v2 | 2022-12-09 | French | Compare |
v3 | 2022-12-09 | English | Compare |
v4 | 2022-12-09 | French | Compare |
v5 | 2022-12-10 | English | Compare |
v6 | 2023-04-12 | English | Compare |
v7 | 2023-04-12 | French | Compare |
v8 | 2023-05-01 | English | Compare |
v9 | 2023-05-01 | French | Compare |
v10 | 2023-05-03 | English | Compare |
Showing 1 to 10 of 10